DF/HCC Calendar
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Ixempra
Sprycel
Erbitux
Full Development
Ipilimumab
Brivanib
Tanespimycin
XL-184
Exploratory Development
IGF-R Antagonist
VEGF R-2 Adnectin inhibitor (CT-322)
ErbB/VEGF inhibitor
Anti-CD 137 antibody
Epothilone-Folate
SMO Inhibitor
Cdc7 inhibitor (XL-413)
Anti-CS1 antibody (Elotuzumab)
Adnectin Bispecific inhibitor
RAF Kinase inhibitor (XL-281)
American Association for Cancer Research, Boston Section
Announces the
24th Apffel Memorial Lecture
Thursday, November 19, 2009
3:30-4:30 PM
“Molecular Determinants of Intestinal Differentiation and Tumorigenesis”
Daniel Louvard, Ph.D.
Director, Curie Institute Research Center
Professor, Pasteur Institute
Paris, France
Rabkin Board Room
Shapiro Clinical Center, 10th Floor
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA
Light reception will follow lecture
Parking
East Campus Main Garage: Located off the main entrance to the medical center's Feldberg Building at 330 Brookline
Avenue; convenient for East Campus buildings. Cashier is located off the lobby of the Feldberg building; customers
pay just before returning to their cars.
The Carl J. Shapiro Clinical Center Garage: Underground garage located on Binney Street, off Longwood Avenue.
Cashier is located on the lobby level of the Shapiro Clinical Center; customers pay just before returning to their cars.
Dana-Farber Cancer Institute
Program in Cancer Chemical Biology
Seminar Series
“Biomaterials and biotechnology: From the discovery of
angiogenesis inhibitors to the development of controlled drug
delivery systems and the foundation of tissue engineering”
Robert S. Langer, Sc.D.
David H. Koch Institute Professor
Massachusetts Institute of Technology
Chemical Engineering Department
Cambridge, MA
Abstract
Research starting with the development of novel delivery systems for
macromolecules is discussed. For example, new drug delivery technologies
including nanoparticles and nanotechnology promise to create new treatments
for cancer and other illnesses. They have also been used as essential parts of
the assays used to isolate angiogenesis inhibitors. The creation of new
biomaterials is also discussed. Furthermore, by combining mammalian cells,
including stem cells, with synthetic polymers, new approaches for engineering
tissues are being developed that may someday help repair various tissues.
Thursday, November 19th, 2009
5:00pm
Jimmy Fund Auditorium
Host: Gregory Verdine, Ph.D.
DFCI Tel: 617-632-4502
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer CenterDesignated by the National Cancer Institute